Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 12 years and 8 months old girl with tuberous sclerosis developed focal motor and sensory
seizures
and hemiplegias initially right-sided and later left-sided. Cerebral angiography showed bilateral and symmetrical vascular network with teleangiectasias in the region of the basal ganglia and bilateral stenoses and ectasias of the middle cerebral artery. It is discussed whether this is a case of atypical
Moyamoya disease
or whether the bilateral basal networks are blood vessel dysplasias and part of the neurocutaneous phakomatosis.
...
PMID:[Moyamoya like vascular disease in tuberous sclerosis (author's transl)]. 733 98
Twenty-three patients with epileptic type
moyamoya
disease are reviewed among 200
moyamoya
disease patients. Ten boys and 13 girls aged 5 months to 12 years were followed over 6 months to 17.3 years. Six had generalized seizure and 17 had focal
seizure
. Operations were performed within 1 year in eight patients, within 1-3 years in five, and more than 3 years after onset in 10. Nineteen patients improved and suffered no
seizure
without receiving antiepileptic drugs, but four patients developed true epilepsy and three of these suffered cerebral infarction. Multivariate analyses showed that toddlers aged less than 1 year and mild or severe abnormal computed tomographic (CT) findings correlated with a bad outcome. This study showed that epileptic type
moyamoya
disease has the same clinical features as transient ischemic attack or infarction type. Age under 1 year and CT abnormalities indicate a poor prognosis and necessity for early reconstructive surgery.
...
PMID:Long-term follow-up study of "epileptic type" moyamoya disease in children. 750 1
Moyamoya disease
is a cerebrovascular disease characterized radiologically by progressive narrowing and occlusion of the arteries contributing to the circle of Willis and its branches. There is formation of an exuberant collateral network of blood vessels at the base of the brain, which is thought to arise in response to chronic ischemia. Clinically, the course is variable, with patients having repeated transient ischemic attacks, strokes, migraine, and
seizures
. Effective treatment is not available. The etiology and pathophysiology of
moyamoya
disease are largely unknown. Two patients with arteriographically proven
moyamoya
disease were identified. Both patients were symptomatic before age 5 years. Despite successful encephaloduroarteriosynangiosis revascularization procedures, they continued to experience an inexorable downhill course. A calcium channel blocker (nicardipine HCl) was introduced in order to prevent further symptoms. After the introduction of nicardipine, no further strokes occurred in either patient. There were no further episodes of transient ischemic attacks,
seizures
, or headache in one patient and decreased frequency in the other. In patients with
moyamoya
disease, nicardipine may have a beneficial effect on cerebral hemodynamics and may prevent ischemic sequelae by optimizing existing collateral circulation.
...
PMID:Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease. 782 27
A previously healthy 4-year-old female presented with an 18-month history of frequent headaches and
seizures
. Magnetic resonance imaging (MRI) and angiography revealed severe stenosis of the left proximal intracranial carotid artery, with bilateral development of
moyamoya
vessels, left greater than right. A diagnosis of
moyamoya
disease was made, and the patient was scheduled for surgical correction consisting of an encephalo-duro-arterio-synangiosis.
Moyamoya disease
is a rare, occlusive cerebrovascular disorder characterized by bilateral stenosis of the internal carotid arteries and their branches. While its etiology is currently uncertain, recent studies indicate that focal arteritis, secondary to an antigen-antibody reaction, leads to the development of the stenosis. Anesthetic management of patients with
moyamoya
disease focuses on maintenance of adequate cerebral blood flow, normalization of intracranial pressure, and avoidance of both cerebral vasoconstriction and vasodilation. Several anesthetic techniques have been successfully employed; one such method is presented.
...
PMID:Anesthetic management of a patient with moyamoya disease: a case report. 829 89
Moyamoya disease
is a rare condition characterized by narrowing and occlusion of the internal carotid arteries. The disease usually presents as alteration of consciousness caused by intracranial hemorrhage. We describe a case of
moyamoya
disease presenting as
seizures
in a pregnant patient. The characteristic angiographic appearances and plan of management are described.
...
PMID:Moyamoya disease in pregnancy: a case report. 836 54
Moyamoya
is an obstructive cerebrovascular disease characterized by a cerebral angiographic picture of stenosis or occlusion of main cerebral arteries with an abnormal vascular network at the base of the brain. No definitive cause has been found for this disease and opinion is still divided between a congenital and an acquired etiology. Hemiplegia of sudden onset and epileptic
seizures
are the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. We report a new case of childhood
moyamoya
with clinical onset of the neurological symptoms within the 3rd year of life; during the child's illness the maternal grandmother presented with
moyamoya
disease too. Antiaggregating and calcium-antagonist drugs seem effective in preventing further vascular accidents, while a surgical approach is not possible. Computed tomography, single positron emission computed tomography, and magnetic resonance imaging are very useful in the diagnosis of this rare disease.
...
PMID:Moyamoya disease in childhood: a familial case report. 840 3
Moyamoya
syndrome is defined as the development of collateral anastomosis pathways at the base of the brain, associated with chronic progressive stenosis of the carotid fork. Both reconstructive vascular surgery and conservative strategies are used to treat this syndrome, but the latter cannot prevent the disease from progressing. We describe the procedure of encephalo-duro-arterio-myo-synangiosis (EDAMS), and report the results in 17 patients (28 sides) who underwent EDAMS. The clinical symptoms of
moyamoya
disease include transient ischemic attacks, reversible ischemic neurological deficits, stroke,
seizures
, Gerstmann's syndrome, involuntary movements, or mental retardation resulting from the lack of cerebral blood flow. The clinical results of EDAMS were poor in one patient, fair in two, good in five, excellent in eight, and fair on one side and excellent on the other side in one patient. Postoperative angiograms showed widespread collateral circulation on the ischemic brain surface in patients undergoing EDAMS.
...
PMID:Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms. 847 42
Unilateral
Moyamoya disease
presents as unilateral stenosis or obstruction of the supraclinoid internal carotid artery, which causes cerebral hypoperfusion resulting in
seizures
or TIA-like attacks. In severe cases, surgical treatment is performed with superficial temporal artery-middle cerebral artery anastomosis. In mild cases, conservative management is the treatment of choice. Flunarizine is a calcium ion anti-blocking agent, whose primary effect is that the cerebral vessels have been used for the treatment of postcerebrovascular disorders. Recently, it has been suggested that flunarizine could be used to treat
Moyamoya disease
. This report documents the efficacy of flunarizine to improve regional cerebral perfusion in
Moyamoya disease
.
...
PMID:Cerebral perfusion imaging evaluates pharmacologic treatment of unilateral moyamoya disease. 854 9
Moya-Moya disease is a chronic infrequent vasculopathy. Occasionally such abnormalities are found in association with one of many conditions, in these cases the angiographic abnormality should be termed Moya-Moya syndrome rather than Moya-Moya disease. Although in children the usual manifestations are ischemic events and
seizures
. This clinical presentation is infrequent in adults. We present a 42-years-old man with a 1-month history of recurrent right sided partial somatosensorial
seizures
, later he presented a left parietal infarction, the angiographic findings were compatible with
moyamoya
syndrome.
...
PMID:[Somatosensory focal seizures as an onset form in adult Moyamoya syndrome]. 855 29
The authors report a unique case involving a 2-year-old child with idiopathic
moyamoya
disease who presented with cerebral infarctions and
seizures
. On initial evaluation, computerized tomography (CT) showed a left parietal infarct and angiograms demonstrated early
moyamoya
disease with no evidence of arteriovenous malformation (AVM). Approximately 9 years later, angiography and magnetic resonance (MR) imaging revealed an AVM centered on the same region of the left parietal lobe. Angiographic, CT, and MR images are presented that demonstrate the progression of
moyamoya
disease and de novo development of the AVM in the infarct site. The possible role of angiogenesis in the etiology of acquired AVMs and
moyamoya
disease is discussed.
...
PMID:Acquired cerebral arteriovenous malformation in a child with moyamoya disease. Case report. 861 63
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>